AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should ...

IP protocol suite market is competitive both in terms of cost and delivery. It is prone to the vagaries of the highly volatile telecom market and rapidly evolving technology standards. Increasingly, ...

BASEL, Switzerland, April 23, 2024 /PRNewswire/ -- Risklick, a spin-off from the University of Bern, launched Protocol AI, the first software of its kind, marking a turning point in the pharmaceutical ...

Protocol Builder 2.0 leverages AI to minimize administrative burden, allowing experienced and new researchers to focus on scientific innovation. This tech-enabled system supports the development of ...

Using a clinical trial schedule of assessments (SOA) as a quality improvement tool. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text ...

Automate content generation: AI can generate initial drafts of protocols based on user-provided synopses. Leverage data-driven insights: By training on extensive datasets of clinical trial protocols, ...

Industry-wide, clinical trial protocols continue to increase in complexity over time. This webinar adds to the growing evidence of which elements of trial design and strategy correlate with lower ...